CPD Accredited Obesity Training for Healthcare Professionals

Dr Alun Davies is one of the UK's leading voices in obesity medicine and primary care weight management. He has played an instrumental role in shaping national policy, contributing to NICE guideline development and working directly with regulatory bodies to help write the licences for several landmark weight loss and diabetes medications — including the GLP-1 and dual agonist agents now transforming clinical practice.

His industry career spans senior roles at three of the world's foremost pharmaceutical companies — Amgen, Eli Lilly, and Novo Nordisk — including time at Novo Nordisk's global headquarters in Copenhagen. This breadth of experience gives him a uniquely informed perspective on the evidence base, the regulatory landscape, and the real-world clinical application of obesity pharmacotherapy.

Alun is the founder of Weight Loss Wales, Wales' first private obesity service that was fully accredited as an online clinic and has helped hundreds of patients achieve meaningful, sustained weight loss. He is a GP with extensive experience in sports medicine including professional sport and at the Olympic Games — a background that informs his deep understanding of exercise physiology, metabolic health, and behaviour change.

In academia, Alun serves as Programme Director for the Masters course in Clinical Weight Management at the University of South Wales — one of the few postgraduate programmes of its kind in the UK. He brings this same rigour and clinical depth to the Primary Care Obesity Society courses, ensuring every delegate leaves with the knowledge and confidence to transform their practice.